AURORA CANNABIS INC ACB

Latest FY: 2026 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $3.89
Market Cap $230.00M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↓-6.6% YoY
$320.59M
Full year reported
Net Income ↓-8,645.8% YoY
-$135.96M
Net Margin: -42.4%
Free Cash Flow ↓-206.5% YoY
-$19.09M
FCF Yield: -8.30%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-26.6%
ROA: -22.6%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ACB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2018 $55.2M $35.6M $69.2M 0.00%
FY 2019 $247.9M +349.2% $159.8M $-297.9M -530.4% 0.00%
FY 2020 $278.9M +12.5% $-33.5M $-3,310.3M -1,011.1% 0.00% $47.9M $-301.2M
FY 2021 $245.3M -12.1% $-21.6M $-695.1M +79.0% 0.00% $34.2M $-16.1M +94.7%
FY 2022 $221.3M -9.8% $21.2M $-1,718.0M -147.2% 0.00% $27.7M $15.2M +194.1%
FY 2023 0.00%
FY 2024 $270.3M $131.5M $-69.3M 0.00% $11.7M $7.1M
FY 2025 $343.3M +27.0% $187.6M $1.6M +102.3% 0.00% $6.8M $-6.2M -187.2%
FY 2026 $320.6M -6.6% $158.8M $-136.0M -8,645.8% 0.00% $2.4M $-19.1M -206.5%
$

Valuation

Market Price $3.89
Market Cap $230.00M
Enterprise Value $165.31M
P/E Ratio N/A
P/B Ratio 0.45
FCF Yield -8.30%
Dividend Yield 0.00%
Shares Outstanding 59,126,600
%

Profitability & Margins

Gross Margin 49.53%
Operating Margin -17.63%
Net Margin -42.41%
Return on Equity (ROE) -26.56%
Return on Assets (ROA) -22.62%
Asset Turnover 0.53x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 1.94
Cash Ratio 11.29
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $64.69M
Total Debt N/A
Book Value / Share $8.66
💧

Cash Flow Efficiency

Operating Cash Flow $2.35M
Capital Expenditures (CapEx) $21.45M
Free Cash Flow -$19.09M
OCF / Revenue 0.73%
FCF / Revenue -5.96%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $8.66
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2026)

Total Assets $601.09M
Total Liabilities $89.25M
Stockholders' Equity $511.83M
Current Assets $11.12M
Current Liabilities $5.73M